ArticleThe oncologist2024

Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy.

Dylan Fortman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.